STERIS (STE) Revenue — Quarter Ended Dec 31, 2024
Revenue rose in the quarter, driven by improved performance across the business. Sequential and year-over-year comparisons both showed gains.
Key takeaway
Quarter ended Dec 31, 2024 · FY2025 Q3
Revenue rose in the quarter, driven by improved performance across the business. Sequential and year-over-year comparisons both showed gains.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.4B
Revenue reported for this quarter.
Quarter-over-quarter
+3.1%
Change from the immediately preceding quarter.
Year-over-year
+5.6%
Change from the comparable year-ago quarter.
Trailing four quarters
$5.4B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2024 | $1.4B | +10.8% |
| Jun 30, 2024 | $1.3B | +8.1% |
| Sep 30, 2024 | $1.3B | +7.3% |
| Dec 31, 2024 | $1.4B | +5.6% |
Revenue performance
Revenue increased compared to the prior quarter, continuing the upward trend seen in recent periods.
Quarterly comparison
Compared to the same quarter last year, revenue was higher, reflecting sustained demand. The sequential increase from the preceding quarter also contributed to the positive performance.
What to watch
Monitor whether revenue growth can be maintained against prior year comparisons in upcoming quarters.